PMA P100024S003

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S003
Product code
NYQ
Decision date
2012-11-27
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
APPROVAL FOR A CHANGE IN THE MOUNTING MEDIUM REAGENT SUPPLIED IN THE KIT.

Current openFDA PMA Record#

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S003
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2012-11-27
Decision code
APPR
Date received
2012-09-20
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL FOR A CHANGE IN THE MOUNTING MEDIUM REAGENT SUPPLIED IN THE KIT.